Boston Scientific Corporation Share Price & Technical Analysis

BSX · $48.97 (+2.66%)

Healthcare / Medical Devices

AI Score 20 · Bearish

$48.97

+2.66%

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGl

Price chart

Seasonality

Jun has 3 positive and 2 negative years (last 5 years shown)

-1% return in Jun, 3% avg return in past 3 year Jun month.

-65% return in 2026, 25% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-2%-18%-18%-10%-17%-1%-65%
2514%2%-4%2%2%3%-2%1%-7%3%1%-6%8%
2410%3%3%5%6%2%-4%10%3%0%8%-2%44%
23-1%0%7%4%-1%5%-4%4%-3%-2%9%3%23%
221%3%0%-5%-3%-9%10%-1%-4%10%6%2%9%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 20/100

Bearish · Downtrend · Weak

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$71.53B

P/E ratio

20.14

52W high

$109.5

52W low

$47.17

Volume

19,17,117

Beta

0.62

Related stocks in Healthcare

Frequently asked questions

What is Boston Scientific Corporation share price today?
Boston Scientific Corporation (BSX) last traded around $48.97 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does BSX have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BSX. Download the app for real-time alerts.
How can I analyze Boston Scientific Corporation stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro